The interleukin-4 expression in patients with severe sepsis
Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)–4 and IL-4 δ2 in patients with severe sepsis. By nested reverse transcriptase–polymerase chain reaction and the e...
Saved in:
Published in | Journal of critical care Vol. 23; no. 4; pp. 519 - 524 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.12.2008
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)–4 and IL-4
δ2 in patients with severe sepsis.
By nested reverse transcriptase–polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4
δ2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively.
The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4
δ2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4
δ2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4
δ2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4
δ2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors.
The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4
δ2/IL-4 ratio might be served as the net immunity of IL-4 activity. |
---|---|
AbstractList | Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)–4 and IL-4
δ2 in patients with severe sepsis.
By nested reverse transcriptase–polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4
δ2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively.
The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4
δ2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4
δ2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4
δ2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4
δ2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors.
The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4
δ2/IL-4 ratio might be served as the net immunity of IL-4 activity. Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)-4 and IL-4δ 2 in patients with severe sepsis. By nested reverse transcriptase-polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4δ 2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively. The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4δ 2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4δ 2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4δ 2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4δ 2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors. The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4δ 2/IL-4 ratio might be served as the net immunity of IL-4 activity. Abstract Purpose Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)–4 and IL-4 δ 2 in patients with severe sepsis. Materials and Methods By nested reverse transcriptase–polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4 δ 2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively. Results The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4 δ 2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4 δ 2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4 δ 2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4 δ 2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors. Conclusions The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4 δ 2/IL-4 ratio might be served as the net immunity of IL-4 activity. Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)-4 and IL-4delta2 in patients with severe sepsis.PURPOSESepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)-4 and IL-4delta2 in patients with severe sepsis.By nested reverse transcriptase-polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4delta2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively.MATERIALS AND METHODSBy nested reverse transcriptase-polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4delta2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively.The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4delta2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4delta2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4delta2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4delta2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors.RESULTSThe IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4delta2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4delta2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4delta2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4delta2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors.The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4delta2/IL-4 ratio might be served as the net immunity of IL-4 activity.CONCLUSIONSThe IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4delta2/IL-4 ratio might be served as the net immunity of IL-4 activity. Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the expression of interleukin (IL)-4 and IL-4delta2 in patients with severe sepsis. By nested reverse transcriptase-polymerase chain reaction and the expression of glyceraldehydes-3-phosphate dehydrogenase as the internal reference, the expression levels of IL-4 and IL-4delta2 were determined in peripheral blood mononuclear cells (PBMCs) of 76 patients with severe sepsis and were immediately admitted to an intensive care unit. Plasma IL-4 level was measured by enzyme-linked immunosorbent assay. Clinical characteristics were monitored and recorded prospectively. The IL-4 messenger RNA (mRNA) expression in PBMCs of patients who had survived was significantly higher than that of those who had died. The IL-4delta2/IL-4 ratio in PBMCs of patients who had survived was significantly lower than that of those who had died. The IL-4delta2 expression did not differ between survivors and nonsurvivors. After regression analysis, the IL-4delta2/IL-4 ratio still was an independent factor for death in patients with severe sepsis. The expression of IL-4delta2 mRNA was positively correlated with that of IL-4 mRNA in patients with severe sepsis. The plasma IL-4 levels in septic patients on admission day did not differ between survivors and nonsurvivors. The IL-4 mRNA expression might be associated with survival in patients with severe sepsis. The IL-4delta2/IL-4 ratio might be served as the net immunity of IL-4 activity. |
Author | Wu, Huang-Pin Chen, Chian-Kuang Liu, Yu-Chih Chuang, Duen-Yau Chung, Kong Wu, Chia-Ling Tseng, Jo-Chi |
Author_xml | – sequence: 1 givenname: Huang-Pin surname: Wu fullname: Wu, Huang-Pin organization: Division of Pulmonary Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan, ROC – sequence: 2 givenname: Chia-Ling surname: Wu fullname: Wu, Chia-Ling organization: Department of Chemistry, National Chung-Hsing University, Taichung 402, Taiwan, ROC – sequence: 3 givenname: Chian-Kuang surname: Chen fullname: Chen, Chian-Kuang organization: Chang Gung University College of Medicine, Taoyuan 333, Taiwan, ROC – sequence: 4 givenname: Kong surname: Chung fullname: Chung, Kong organization: Chang Gung University College of Medicine, Taoyuan 333, Taiwan, ROC – sequence: 5 givenname: Jo-Chi surname: Tseng fullname: Tseng, Jo-Chi organization: Division of Pulmonary Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan, ROC – sequence: 6 givenname: Yu-Chih surname: Liu fullname: Liu, Yu-Chih organization: Division of Pulmonary Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan, ROC – sequence: 7 givenname: Duen-Yau surname: Chuang fullname: Chuang, Duen-Yau email: chuang@dragon.nchu.edu.tw organization: Department of Chemistry, National Chung-Hsing University, Taichung 402, Taiwan, ROC |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19056016$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl1L3jAYhoM49NX5BzwYhcHO2iVN81E3BkPmBwge6I5Dmj7F1L5pTVI3__1SXjfhhenRc_Dc151w8RygXTc6QOiY4IJgwj_3RW-8KUqMRUFIgbHcQSvCmMglJ2wXrbCUNK-riuyjgxB6jImglO2hfVJjxlPFCn25vYPMugh-gPneurzK4PfkIQQ7urTIJh0tuBiyXzbeZQEewUMaU7DhPXrX6SHA0fM8RD_PftyeXuRX1-eXp9-vclNJGXMjdc0pE1xq1soKV6TRRkvOmSC8YWUpMe-atmOdrFqopeaMi050ZUUb07SUHqJPm97Jjw8zhKjWNhgYBu1gnIPitRS4LnEKftwK9uPsXfqbIpjSkgoqeUp9eE7NzRpaNXm71v5J_ZWSAnITMH4MwUOnjI1Jw-ii13ZIXWrxr3q1-FeLf0WISv4TWm6h_9pfg75uIEgSHy14FUxybqC1HkxU7Whfx79t4Wawzho93MMThBcFKpQKq5vlKpajwCIdRM1YKjj5f8Fbr_8BZmrFBg |
CitedBy_id | crossref_primary_10_1016_j_cgh_2019_08_036 crossref_primary_10_3892_etm_2016_3354 crossref_primary_10_1016_j_cyto_2017_09_007 crossref_primary_10_1007_s00740_015_0064_3 crossref_primary_10_1155_2013_165974 crossref_primary_10_1055_a_2114_8333 crossref_primary_10_1016_j_cyto_2011_12_017 crossref_primary_10_1016_j_tria_2022_100170 crossref_primary_10_1055_a_1813_2057 crossref_primary_10_5607_en_2018_27_4_309 crossref_primary_10_1097_ALN_0000000000001031 crossref_primary_10_1089_jir_2014_0119 crossref_primary_10_4161_epi_6_3_14017 crossref_primary_10_1097_TA_0b013e3182115034 crossref_primary_10_1007_s10753_015_0135_z crossref_primary_10_1111_j_1365_2567_2010_03393_x crossref_primary_10_17650_1818_8346_2024_19_4_182_187 crossref_primary_10_1016_j_ccc_2017_08_002 crossref_primary_10_1007_s10096_014_2275_8 crossref_primary_10_1155_2014_269681 crossref_primary_10_1189_jlb_0412214 crossref_primary_10_1055_a_2181_1018 crossref_primary_10_1016_j_ejphar_2023_176043 crossref_primary_10_3892_ijo_2019_4862 crossref_primary_10_1189_jlb_0510271 crossref_primary_10_1016_j_intimp_2018_03_005 crossref_primary_10_1089_jir_2014_0107 crossref_primary_10_1007_s00101_014_2402_z crossref_primary_10_56986_pim_2023_06_005 crossref_primary_10_1016_j_jprot_2012_05_018 |
Cites_doi | 10.1097/00003246-198510000-00009 10.1164/ajrccm.164.6.2012138 10.1006/cimm.1998.1431 10.1056/NEJMra043632 10.1016/0161-5890(95)00154-9 10.4049/jimmunol.156.2.435 10.4049/jimmunol.172.11.6938 10.1385/IR:24:3:273 10.1067/msy.2000.107282 10.1002/(SICI)1521-4141(199802)28:02<610::AID-IMMU610>3.0.CO;2-5 10.1006/jsre.2002.6417 10.1016/j.tube.2006.11.001 10.1056/NEJMra021333 10.1016/S0014-4835(02)00248-8 10.1097/01.CCM.0000050454.01978.3B 10.1378/chest.111.5.1306 10.1136/thorax.56.7.541 10.1097/01.shk.0000068322.08268.b4 10.1002/(SICI)1521-4141(199908)29:08<2400::AID-IMMU2400>3.0.CO;2-E 10.1097/00003246-199510000-00007 10.1001/archsurg.1995.01430110017004 |
ContentType | Journal Article |
Copyright | 2008 Elsevier Inc. Elsevier Inc. |
Copyright_xml | – notice: 2008 Elsevier Inc. – notice: Elsevier Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ASE AZQEC BENPR CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH K6X K9. KB0 M0S M1P M2O MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 |
DOI | 10.1016/j.jcrc.2007.11.008 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database (Proquest) British Nursing Index ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni) Medical Database Research Library Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition British Nursing Index with Full Text British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Research Library Prep MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1557-8615 |
EndPage | 524 |
ExternalDocumentID | 2735005351 19056016 10_1016_j_jcrc_2007_11_008 S0883944107001955 1_s2_0_S0883944107001955 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 2FS 354 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 7RV 7X7 88E 8FI 8FJ 8G5 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABUWG ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFKRA AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN AZQEC BENPR BKEYQ BKOJK BLXMC BNPGV BNQBC BPHCQ BVXVI C45 CCPQU CS3 DU5 DWQXO EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HDV HMCUK HMK HMO HVGLF HZ~ IHE J1W KOM LX1 M1P M29 M2O M41 MO0 N9A NAPCQ O-L O9- OA0 OAUVE OBH OHH OM- OVD OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q38 R2- ROL RPZ SAE SDF SDG SEL SES SEW SPCBC SSH SSZ SV3 T5K TEORI UKHRP UNMZH UV1 WHG WOW WUQ Z5R ZB8 ZGI ZY1 ~G- 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG AAIAV ABLVK ABYKQ AFDAS AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7XB 8FK ASE FPQ K6X K9. MBDVC PKEHL PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c488t-c8a9635768a5d84041baca8665716b522806fbdf5f84de98a6567f7f243bcbd33 |
IEDL.DBID | .~1 |
ISSN | 0883-9441 1557-8615 |
IngestDate | Fri Jul 11 00:07:51 EDT 2025 Sat Aug 23 14:02:18 EDT 2025 Thu Apr 03 06:58:12 EDT 2025 Thu Apr 24 23:04:15 EDT 2025 Tue Jul 01 03:14:17 EDT 2025 Fri Feb 23 02:22:23 EST 2024 Sun Feb 23 10:19:23 EST 2025 Tue Aug 26 16:32:07 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Human Interleukin-4 Sepsis Interleukin-4 δ2 Cytokines |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c488t-c8a9635768a5d84041baca8665716b522806fbdf5f84de98a6567f7f243bcbd33 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 19056016 |
PQID | 1033237386 |
PQPubID | 1226342 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_69870920 proquest_journals_1033237386 pubmed_primary_19056016 crossref_citationtrail_10_1016_j_jcrc_2007_11_008 crossref_primary_10_1016_j_jcrc_2007_11_008 elsevier_sciencedirect_doi_10_1016_j_jcrc_2007_11_008 elsevier_clinicalkeyesjournals_1_s2_0_S0883944107001955 elsevier_clinicalkey_doi_10_1016_j_jcrc_2007_11_008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-12-01 |
PublicationDateYYYYMMDD | 2008-12-01 |
PublicationDate_xml | – month: 12 year: 2008 text: 2008-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Philadelphia |
PublicationTitle | Journal of critical care |
PublicationTitleAlternate | J Crit Care |
PublicationYear | 2008 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Glare, Divjak, Bailey (bib17) 2001; 56 Reddy, Chen, Tekchandani (bib2) 2001; 24 Levy, Fink, Marshall (bib7) 2003; 31 Knaus, Draper, Wagner (bib8) 1985; 13 Hynninen, Pettila, Takkunen (bib20) 2003; 20 Fujitsu, Fukuda, Kumagai (bib3) 2003; 76 Alms, Atamas, Yurovsky (bib15) 1996; 33 Baumhofer, Beinhauer, Wang (bib10) 1998; 28 Marshall, Cook, Christou (bib9) 1995; 23 Russell (bib6) 2006; 355 Headley, Tolley, Meduri (bib19) 1997; 111 Hultgren, Kopf, Tarkowski (bib13) 1999; 29 Seah, Gao, Hopkin (bib16) 2001; 164 Dheda, Chang, Huggett (bib21) 2007; 87 Hotchkiss, Karl (bib1) 2003; 348 Atamas, Choi, Yurovsky (bib4) 1996; 156 Demissie, Abebe, Aseffa (bib14) 2004; 172 Hess, Henry-Stanley, Erickson (bib11) 2002; 104 Arinobu, Atamas, Otsuka (bib5) 1999; 191 DiPiro, Howdieshell, Goddard (bib18) 1995; 130 Song, Chung, Chaudry (bib12) 2000; 128 Dheda (10.1016/j.jcrc.2007.11.008_bib21) 2007; 87 Arinobu (10.1016/j.jcrc.2007.11.008_bib5) 1999; 191 Hultgren (10.1016/j.jcrc.2007.11.008_bib13) 1999; 29 Knaus (10.1016/j.jcrc.2007.11.008_bib8) 1985; 13 Hess (10.1016/j.jcrc.2007.11.008_bib11) 2002; 104 Hotchkiss (10.1016/j.jcrc.2007.11.008_bib1) 2003; 348 Reddy (10.1016/j.jcrc.2007.11.008_bib2) 2001; 24 Fujitsu (10.1016/j.jcrc.2007.11.008_bib3) 2003; 76 Marshall (10.1016/j.jcrc.2007.11.008_bib9) 1995; 23 Alms (10.1016/j.jcrc.2007.11.008_bib15) 1996; 33 Glare (10.1016/j.jcrc.2007.11.008_bib17) 2001; 56 Song (10.1016/j.jcrc.2007.11.008_bib12) 2000; 128 Baumhofer (10.1016/j.jcrc.2007.11.008_bib10) 1998; 28 Seah (10.1016/j.jcrc.2007.11.008_bib16) 2001; 164 Headley (10.1016/j.jcrc.2007.11.008_bib19) 1997; 111 Hynninen (10.1016/j.jcrc.2007.11.008_bib20) 2003; 20 DiPiro (10.1016/j.jcrc.2007.11.008_bib18) 1995; 130 Atamas (10.1016/j.jcrc.2007.11.008_bib4) 1996; 156 Russell (10.1016/j.jcrc.2007.11.008_bib6) 2006; 355 Levy (10.1016/j.jcrc.2007.11.008_bib7) 2003; 31 Demissie (10.1016/j.jcrc.2007.11.008_bib14) 2004; 172 |
References_xml | – volume: 29 start-page: 2400 year: 1999 end-page: 2405 ident: bib13 article-title: Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4–deficient mice depends on the genetic background of the host publication-title: Eur J Immunol – volume: 87 start-page: 237 year: 2007 end-page: 241 ident: bib21 article-title: The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not publication-title: Tuberculosis – volume: 20 start-page: 1 year: 2003 end-page: 4 ident: bib20 article-title: Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis publication-title: Shock – volume: 24 start-page: 273 year: 2001 end-page: 287 ident: bib2 article-title: Sepsis-induced immunosuppression: from bad to worse publication-title: Immunol Res – volume: 13 start-page: 818 year: 1985 end-page: 829 ident: bib8 article-title: APACHE II: a severity of disease classification system publication-title: Crit Care Med – volume: 191 start-page: 161 year: 1999 end-page: 167 ident: bib5 article-title: Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells publication-title: Cell Immunol – volume: 76 start-page: 107 year: 2003 end-page: 114 ident: bib3 article-title: IL-4–induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts publication-title: Exp Eye Res – volume: 104 start-page: 88 year: 2002 end-page: 94 ident: bib11 article-title: Effect of tumor necrosis factor alpha, interferon gamma, and interleukin-4 on bacteria-enterocyte interactions publication-title: J Surg Res – volume: 355 start-page: 1699 year: 2006 end-page: 1713 ident: bib6 article-title: Management of sepsis publication-title: N Engl J Med – volume: 130 start-page: 1159 year: 1995 end-page: 1162 ident: bib18 article-title: Association of interleukin-4 plasma levels with traumatic injury and clinical course publication-title: Arch Surg – volume: 31 start-page: 1250 year: 2003 end-page: 1256 ident: bib7 article-title: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference publication-title: Crit Care Med – volume: 128 start-page: 133 year: 2000 end-page: 138 ident: bib12 article-title: IL-4–induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis publication-title: Surgery – volume: 28 start-page: 610 year: 1998 end-page: 615 ident: bib10 article-title: Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence publication-title: Eur J Immunol – volume: 33 start-page: 361 year: 1996 end-page: 370 ident: bib15 article-title: Generation of a variant of human interleukin-4 by alternative splicing publication-title: Mol Immunol – volume: 164 start-page: 1016 year: 2001 end-page: 1018 ident: bib16 article-title: Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma publication-title: Am J Respir Crit Care Med – volume: 56 start-page: 541 year: 2001 end-page: 548 ident: bib17 article-title: The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma publication-title: Thorax – volume: 348 start-page: 138 year: 2003 end-page: 150 ident: bib1 article-title: The pathophysiology and treatment of sepsis publication-title: N Engl J Med – volume: 156 start-page: 435 year: 1996 end-page: 441 ident: bib4 article-title: An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4–stimulated T cell proliferation publication-title: J Immunol – volume: 111 start-page: 1306 year: 1997 end-page: 1321 ident: bib19 article-title: Infections and the inflammatory response in acute respiratory distress syndrome publication-title: Chest – volume: 23 start-page: 1638 year: 1995 end-page: 1652 ident: bib9 article-title: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome publication-title: Crit Care Med – volume: 172 start-page: 6938 year: 2004 end-page: 6943 ident: bib14 article-title: Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of T publication-title: J Immunol – volume: 13 start-page: 818 issue: 10 year: 1985 ident: 10.1016/j.jcrc.2007.11.008_bib8 article-title: APACHE II: a severity of disease classification system publication-title: Crit Care Med doi: 10.1097/00003246-198510000-00009 – volume: 164 start-page: 1016 issue: 6 year: 2001 ident: 10.1016/j.jcrc.2007.11.008_bib16 article-title: Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.164.6.2012138 – volume: 191 start-page: 161 issue: 2 year: 1999 ident: 10.1016/j.jcrc.2007.11.008_bib5 article-title: Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells publication-title: Cell Immunol doi: 10.1006/cimm.1998.1431 – volume: 355 start-page: 1699 issue: 16 year: 2006 ident: 10.1016/j.jcrc.2007.11.008_bib6 article-title: Management of sepsis publication-title: N Engl J Med doi: 10.1056/NEJMra043632 – volume: 33 start-page: 361 issue: 4–5 year: 1996 ident: 10.1016/j.jcrc.2007.11.008_bib15 article-title: Generation of a variant of human interleukin-4 by alternative splicing publication-title: Mol Immunol doi: 10.1016/0161-5890(95)00154-9 – volume: 156 start-page: 435 issue: 2 year: 1996 ident: 10.1016/j.jcrc.2007.11.008_bib4 article-title: An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4–stimulated T cell proliferation publication-title: J Immunol doi: 10.4049/jimmunol.156.2.435 – volume: 172 start-page: 6938 issue: 11 year: 2004 ident: 10.1016/j.jcrc.2007.11.008_bib14 article-title: Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of TH1 cytokines and the IL-4 antagonist IL-4delta2 publication-title: J Immunol doi: 10.4049/jimmunol.172.11.6938 – volume: 24 start-page: 273 issue: 3 year: 2001 ident: 10.1016/j.jcrc.2007.11.008_bib2 article-title: Sepsis-induced immunosuppression: from bad to worse publication-title: Immunol Res doi: 10.1385/IR:24:3:273 – volume: 128 start-page: 133 issue: 2 year: 2000 ident: 10.1016/j.jcrc.2007.11.008_bib12 article-title: IL-4–induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis publication-title: Surgery doi: 10.1067/msy.2000.107282 – volume: 28 start-page: 610 issue: 2 year: 1998 ident: 10.1016/j.jcrc.2007.11.008_bib10 article-title: Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence publication-title: Eur J Immunol doi: 10.1002/(SICI)1521-4141(199802)28:02<610::AID-IMMU610>3.0.CO;2-5 – volume: 104 start-page: 88 issue: 2 year: 2002 ident: 10.1016/j.jcrc.2007.11.008_bib11 article-title: Effect of tumor necrosis factor alpha, interferon gamma, and interleukin-4 on bacteria-enterocyte interactions publication-title: J Surg Res doi: 10.1006/jsre.2002.6417 – volume: 87 start-page: 237 issue: 3 year: 2007 ident: 10.1016/j.jcrc.2007.11.008_bib21 article-title: The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not publication-title: Tuberculosis doi: 10.1016/j.tube.2006.11.001 – volume: 348 start-page: 138 issue: 2 year: 2003 ident: 10.1016/j.jcrc.2007.11.008_bib1 article-title: The pathophysiology and treatment of sepsis publication-title: N Engl J Med doi: 10.1056/NEJMra021333 – volume: 76 start-page: 107 issue: 1 year: 2003 ident: 10.1016/j.jcrc.2007.11.008_bib3 article-title: IL-4–induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts publication-title: Exp Eye Res doi: 10.1016/S0014-4835(02)00248-8 – volume: 31 start-page: 1250 issue: 4 year: 2003 ident: 10.1016/j.jcrc.2007.11.008_bib7 article-title: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference publication-title: Crit Care Med doi: 10.1097/01.CCM.0000050454.01978.3B – volume: 111 start-page: 1306 issue: 5 year: 1997 ident: 10.1016/j.jcrc.2007.11.008_bib19 article-title: Infections and the inflammatory response in acute respiratory distress syndrome publication-title: Chest doi: 10.1378/chest.111.5.1306 – volume: 56 start-page: 541 issue: 7 year: 2001 ident: 10.1016/j.jcrc.2007.11.008_bib17 article-title: The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma publication-title: Thorax doi: 10.1136/thorax.56.7.541 – volume: 20 start-page: 1 issue: 1 year: 2003 ident: 10.1016/j.jcrc.2007.11.008_bib20 article-title: Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis publication-title: Shock doi: 10.1097/01.shk.0000068322.08268.b4 – volume: 29 start-page: 2400 issue: 8 year: 1999 ident: 10.1016/j.jcrc.2007.11.008_bib13 article-title: Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4–deficient mice depends on the genetic background of the host publication-title: Eur J Immunol doi: 10.1002/(SICI)1521-4141(199908)29:08<2400::AID-IMMU2400>3.0.CO;2-E – volume: 23 start-page: 1638 issue: 10 year: 1995 ident: 10.1016/j.jcrc.2007.11.008_bib9 article-title: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome publication-title: Crit Care Med doi: 10.1097/00003246-199510000-00007 – volume: 130 start-page: 1159 issue: 11 year: 1995 ident: 10.1016/j.jcrc.2007.11.008_bib18 article-title: Association of interleukin-4 plasma levels with traumatic injury and clinical course publication-title: Arch Surg doi: 10.1001/archsurg.1995.01430110017004 |
SSID | ssj0017335 |
Score | 1.9794198 |
Snippet | Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains unclear for the... Abstract Purpose Sepsis is a complicated syndrome in which proinflammatory and anti-inflammatory cytokines are expressed simultaneously. However, it remains... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 519 |
SubjectTerms | Aged Annealing Critical Care Cytokines Enzyme-Linked Immunosorbent Assay Female Glyceraldehyde-3-Phosphate Dehydrogenases - blood Hospitals Human Humans Intensive care Interleukin-4 Interleukin-4 - biosynthesis Interleukin-4 δ2 Leukocytes, Mononuclear - metabolism Lymphocytes Male Personal relationships Plasma Polymerase chain reaction Prospective Studies Proteins Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - biosynthesis Sepsis Sepsis - blood Tuberculosis |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8QwEB50BfEivq3PHrxJod0kTYsHEVFE0IsKewtpmoAPuut2F_z5zrRpveh66iGdBCaTyUwy-T6AM2d4UlpMU4UTJuLaEhtgHEdFKXFDcILlnF4jPzymdy_8fiRG_sCt9mWVnU9sHHU5NnRGjqubsSHB8KSXk8-IWKPodtVTaCzDCkGXkVXLUZ9wJZK1BJtZxqIc933_aKat73ozUw9hSCieRC_5-8b0V-DZbEC3G7DuI8fwqp3qTViy1RasPvi78W24wBkPCf1h-mHn769VxEP75ctcK2wIPYRqHdLZa4gD26nFz6R-rXfg5fbm-fou8tQIkcEVN4tMpnNCkkszLUrM0XhSaKMJuw7zn0IQxk3qitIJl_HS5pnGsE066YacFaYoGduFQTWu7D6EXDAjNUZaRhAleJw57DvW0rCC55ktA0g6vSjjccOJvuJDdQVib4p0SYSWEhMKhboM4LyXmbSoGQv_Zp26VfceFD2YQqe-UEr-JmVrvwhrlah6qGL1RPNP0x_L5nmkCED0kj7OaOOHf0c86mxB_QzS22UAp30zrlG6eNGVHc9rleboFfNhHMBea0E_SsljSonTg8VdH8JaU6fSlNEcwWA2ndtjDIZmxUlj8d89wwTG priority: 102 providerName: ProQuest |
Title | The interleukin-4 expression in patients with severe sepsis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0883944107001955 https://www.clinicalkey.es/playcontent/1-s2.0-S0883944107001955 https://dx.doi.org/10.1016/j.jcrc.2007.11.008 https://www.ncbi.nlm.nih.gov/pubmed/19056016 https://www.proquest.com/docview/1033237386 https://www.proquest.com/docview/69870920 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8hJiFe0AYDsjGWB95Q1qS240R7YhWofFWIDalvluPYUhkKVdNKPPG37y5xitAYSHuJpcSOrcvd-S6--x3AgTM8KS26qcIJE3FtqRpgHEdFKXFDcILlnLKRL0fp8IafjcV4BQZdLgyFVXrd3-r0Rlv7Oz1Pzd50Mun9RPmgrE70X5qsN0o051wSl397XIZ5JJK1RTaxc0S9feJMG-N1a2YexpCQPKnE5Mub07-Mz2YTOnkPG956DI_aBX6AFVttwtqlPx_fgu_41UNCgJjd2cXvSRXx0D74UNcKH4QeRrUO6f9riBPbmcVmWk_qj3BzcvxrMIx8eYTIoNTNI5PpnNDk0kyLEv00nhTaaMKvQx-oEIRzk7qidMJlvLR5ptF0k066PmeFKUrGtmG1uq_sLoRcMCM1WltGUFnwOHP47lhLwwqeZ7YMIOnooozHDqcSFneqCxK7VURLKmop0alQSMsADpdjpi1yxqu9WUdu1eWEohZTqNhfHSVfGmVrL4i1SlTdV7H6i1kCEMuRz_jtzRn3Ol5QT5PEjPUJIioN4OvyMcopHb7oyt4vapXmqBnzfhzATstBT0TJY3KL00__uaTPsN4EsTQxNnuwOp8t7Be0lObFfiMKeJVjuQ_vjgbXF1fUnp4PR9j-OB5dXf8Bv1oTTA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRQIuiHcDheYAJxTJie04EUIIAdWWdnuhlfZmHMeWWqrsstlVy5_iNzKTOOmlLKeeckgcS-PxPOyZ7wN4461Ia4dpqvTSJsI4YgNkLKlqhQ7BS14K6kaeHueTU_FtJmdb8GfohaGyysEmdoa6nls6I8fdzXlGMDz5x8WvhFij6HZ1oNDo1eLQ_b7ElK39cPAF1_dtlu1_Pfk8SQKrQGJRWVeJLUxJIGx5YWSN6Y1IK2MNwb5h6lBJgofJfVV76QtRu7IwGPEor3wmeGWrmg5A0eTfQcfLKNlTszHBSxXvCT2LgiclxhmhSaevJzu3ywCZSKihRGd5syP8V6DbObz9h_AgRKrxp161HsGWax7D3Wm4i38C71HDYkKbWF649c-zJhGxuwpltQ2-iANkaxvTWW-ME7ulw8eiPWufwumtCO0ZbDfzxu1ALCS3ymBkZyVRkLPC47-ZUZZXoixcHUE6yEXbgFNOdBkXeihIO9ckSyLQVJjAaJRlBO_GMYsepWPj13wQtx76T9FianQiG0epm0a5Nmz6Vqe6zTTT32n9afmZ6toxZQRyHBnimj5e-e-Mu4Mu6OtJxn0Qwd74Gm0CXfSYxs3Xrc5LtMJlxiJ43mvQtVBKRil4_mLzr_fg3uRkeqSPDo4PX8L9rkamK-HZhe3Vcu1eYSC2ql532h_Dj9vebn8BnkZBSw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB6hRUK9VJS-Qink0J5Q1Gxsx4mqqmoLKyiwQm2RuLmOY0s8lN1udlX4a_11nUmccKHbE6ccHNvSeDyesWe-D-CNM3xYWgxThRMm4toSG2AcR0Up8UBwguWcqpFPxunBGf96Ls5X4E9XC0NplZ1NbAx1OTF0R467m7GEYHjSd86nRZzujT5Of0XEIEUvrR2dRqsiR_b2N4Zv9YfDPVzrt0ky2v_x5SDyDAORQcWdRybTOQGypZkWJYY6fFhoowkCDsOIQhBUTOqK0gmX8dLmmUbvRzrpEs4KU5R0GYrmf1VSVDSA1c_749Nv_RuGZC29Z5axKEevw5fstNlll2bmARQJQ5TILe8_Fv_l9jbH32gdHnu_NfzUKtoTWLHVBqyd-Jf5p_Ae9S0k7InZtV1cXVQRD-2NT7KtsCH0AK51SDe_IU5sZxY_0_qifgZnDyK25zCoJpV9CSEXzEiNfp4RREgeZw7HjrU0rOB5ZssAhp1clPGo5USeca269LRLRbIkOk2J4YxCWQaw2_eZtpgdS_9mnbhVV42K9lPhkbK0l7yvl629CajVUNWJitV3Wn9a_lg2xZkiANH39F5O6738d8atThfU3ST9rghgp29GC0HPPrqyk0Wt0hxtcp7EAbxoNehOKHlMAXm6uXzoHVjDraaOD8dHr-BRkzDT5PNswWA-W9jX6JXNi22v_iH8fOgd9xdIbUbm |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+interleukin-4+expression+in+patients+with+severe+sepsis&rft.jtitle=Journal+of+critical+care&rft.au=Wu%2C+Huang-Pin&rft.au=Wu%2C+Chia-Ling&rft.au=Chen%2C+Chian-Kuang&rft.au=Chung%2C+Kong&rft.date=2008-12-01&rft.pub=Elsevier+Inc&rft.issn=0883-9441&rft.eissn=1557-8615&rft.volume=23&rft.issue=4&rft.spage=519&rft.epage=524&rft_id=info:doi/10.1016%2Fj.jcrc.2007.11.008&rft.externalDocID=S0883944107001955 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08839441%2FS0883944108X0005X%2Fcov150h.gif |